Issn Print: 1567-5769
Publication Date: 2017/07/01
Corrigendum to “First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up” [Int. Immunopharmacol. (2016) 25–31]
Razzaque A. Ahmed; Tegan Nguyen; Srini Kaveri; Zachary S. Spigelman
Author Information: Center for Blistering Diseases, Department of Dermatology, Tufts University School of Medicine, Boston, MA, USA
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.